Circulation. 2003;108:3084-3091
Published online before print November 24, 2003, doi: 10.1161/01.CIR.0000103130.33451.D2
Published online before print November 24, 2003, doi: 10.1161/01.CIR.0000103130.33451.D2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;108:3084-3091.)
© 2003 American Heart Association, Inc.
Clinical Investigation and Reports |
Implantable Cardioverter-Defibrillator Therapy for Prevention of Sudden Death in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
From Divisione di Cardiologia e Patologia Cardiovascolare (D.C., L.L., C.B., F.M., G.B., G.T.), Università di Padova, Padova, Italy; New England Medical Center and Tufts University School of Medicine (M.S.L., N.A.M.E.), Boston, Mass; Centro Cardiologico Monzino (P.D.B), Milano, Italy; Ospedale Mauriziano (F.G.), Torino, Italy; Spedali Riuniti (A.C.), Brescia, Italy; Università di Insubria (J.U.S.), Varese, Italy; Ospedale Civile (D.I.), Legnago, Italy; Ospedale Umberto I (A.R.), Mestre, Italy; Ospedale S. Chiara (M.D.), Trento, Italy; Ospedale Civile Maggiore (G.Z.), Verona, Italy; Ospedale P. Cosma (R.V., P.T.), Camposampiero, Italy; Ospedale Santa Maria del Carmine (G.V.), Rovereto, Italy; Ospedale Civile (P.D.), Conegliano, Italy; and Cardiologia Azienda USL (F.N.), Bologna, Italy.
Correspondence to Gaetano Thiene, MD, Istituto di Anatomia Patologica, Via A. Gabelli, 61-35121 Padova, Italy. E-mail cardpath{at}unipd.it
Received July 16, 2003; revision received September 22, 2003; accepted September 22, 2003.
Background— Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a condition associated with the risk of sudden death (SD).
Methods and Results— We conducted a multicenter study of the impact of the implantable cardioverter-defibrillator (ICD) for prevention of SD in 132 patients (93 males and 39 females, age 40±15 years) with ARVC/D. Implant indications were a history of cardiac arrest in 13 patients (10%), sustained ventricular tachycardia in 82 (62%), syncope in 21 (16%), and other in 16 (12%). During a mean follow-up of 39±25 months, 64 patients (48%) had appropriate ICD interventions, 21 (16%) had inappropriate interventions, and 19 (14%) had ICD-related complications. Fifty-three (83%) of the 64 patients with appropriate interventions received antiarrhythmic drug therapy at the time of first ICD discharge. Programmed ventricular stimulation was of limited value in identifying patients at risk of tachyarrhythmias during the follow-up (positive predictive value 49%, negative predictive value 54%). Four patients (3%) died, and 32 (24%) experienced ventricular fibrillation/flutter that in all likelihood would have been fatal in the absence of the device. At 36 months, the actual patient survival rate was 96% compared with the ventricular fibrillation/flutter-free survival rate of 72% (P<0.001). Patients who received implants because of ventricular tachycardia without hemodynamic compromise had a significantly lower incidence of ventricular fibrillation/flutter (log rank=0.01). History of cardiac arrest or ventricular tachycardia with hemodynamic compromise, younger age, and left ventricular involvement were independent predictors of ventricular fibrillation/flutter.
Conclusions— In patients with ARVC/D, ICD therapy provided life-saving protection by effectively terminating life-threatening ventricular arrhythmias. Patients who were prone to ventricular fibrillation/flutter could be identified on the basis of clinical presentation, irrespective of programmed ventricular stimulation outcome.
Key Words: cardiomyopathy • death, sudden • defibrillation • prevention • tachyarrhythmias
This article has been cited by other articles:
 |
|
 |
|
  D. Corrado, C. Basso, and G. Thiene Arrhythmogenic right ventricular cardiomyopathy: an update Heart, May 1, 2009; 95(9): 766 - 773. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Spirito, C. Autore, C. Rapezzi, P. Bernabo, R. Badagliacca, M. S. Maron, S. Bongioanni, F. Coccolo, N.A. M. Estes, C. S. Barilla, et al. Syncope and Risk of Sudden Death in Hypertrophic Cardiomyopathy Circulation, April 7, 2009; 119(13): 1703 - 1710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Gilljam and C.-H. Bergh Right ventricular cardiomyopathy: timing of heart transplantation in Uhl's anomaly and arrythmogenic right ventricular cardiomyopathy Eur J Heart Fail, January 1, 2009; 11(1): 106 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Behr, C. Dalageorgou, M. Christiansen, P. Syrris, S. Hughes, M. T. Tome Esteban, E. Rowland, S. Jeffery, and W. J. McKenna Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families Eur. Heart J., July 1, 2008; 29(13): 1670 - 1680. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ding, W. Hua, H. Niu, K. Chen, and S. Zhang Primary prevention of sudden cardiac death using implantable cardioverter defibrillators Europace, June 16, 2008; (2008) eun150v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons J. Am. Coll. Cardiol., May 27, 2008; 51(21): e1 - e62. [Full Text] [PDF]
|
|
|
|
|
|
A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation, May 27, 2008; 117(21): e350 - e408. [Full Text] [PDF]
|
|
|
|
|
|
S. Sen-Chowdhry, P. Syrris, and W. J. McKenna Role of Genetic Analysis in the Management of Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy J. Am. Coll. Cardiol., November 6, 2007; 50(19): 1813 - 1821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Stephenson and C. I. Berul Electrophysiological Interventions for Inherited Arrhythmia Syndromes Circulation, August 28, 2007; 116(9): 1062 - 1080. [Full Text] [PDF]
|
|
|
|
|
|
D. Dalal, R. Jain, H. Tandri, J. Dong, S. M. Eid, K. Prakasa, C. Tichnell, C. James, T. Abraham, S. D. Russell, et al. Long-Term Efficacy of Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy J. Am. Coll. Cardiol., July 31, 2007; 50(5): 432 - 440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Maron, P. Spirito, W.-K. Shen, T. S. Haas, F. Formisano, M. S. Link, A. E. Epstein, A. K. Almquist, J. P. Daubert, T. Lawrenz, et al. Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy JAMA, July 25, 2007; 298(4): 405 - 412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J. Am. Coll. Cardiol., September 5, 2006; 48(5): 1064 - 1108. [Full Text] [PDF]
|
|
|
|
|
|
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346. [Full Text] [PDF]
|
|
|
|
|
|
L. Antoniades, A. Tsatsopoulou, A. Anastasakis, P. Syrris, A. Asimaki, D. Panagiotakos, C. Zambartas, C. Stefanadis, W. J. McKenna, and N. Protonotarios Arrhythmogenic right ventricular cardiomyopathy caused by deletions in plakophilin-2 and plakoglobin (Naxos disease) in families from Greece and Cyprus: genotype-phenotype relations, diagnostic features and prognosis Eur. Heart J., September 2, 2006; 27(18): 2208 - 2216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Zipes, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur. Heart J., September 1, 2006; 27(17): 2099 - 2140. [Full Text] [PDF]
|
|
|
|
|
|
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 746 - 837. [Full Text] [PDF]
|
|
|
|
|
|
D. A. Cesario and G. W. Dec Implantable Cardioverter- Defibrillator Therapy in Clinical Practice J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1507 - 1517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Corrado and G. Thiene Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Clinical Impact of Molecular Genetic Studies Circulation, April 4, 2006; 113(13): 1634 - 1637. [Full Text] [PDF]
|
|
|
|
|
|
D. Dalal, L. H. Molin, J. Piccini, C. Tichnell, C. James, C. Bomma, K. Prakasa, J. A. Towbin, F. I. Marcus, P. J. Spevak, et al. Clinical Features of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Associated With Mutations in Plakophilin-2 Circulation, April 4, 2006; 113(13): 1641 - 1649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Goldberger and R. Lampert Implantable Cardioverter-Defibrillators: Expanding Indications and Technologies JAMA, February 15, 2006; 295(7): 809 - 818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Strickberger, D. W. Benson, I. Biaggioni, D. J. Callans, M. I. Cohen, K. A. Ellenbogen, A. E. Epstein, P. Friedman, J. Goldberger, P. A. Heidenreich, et al. AHA/ACCF Scientific Statement on the Evaluation of Syncope: From the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation In Collaboration With the Heart Rhythm Society J. Am. Coll. Cardiol., January 17, 2006; 47(2): 473 - 484. [Full Text] [PDF]
|
|
|
|
|
|
S. A. Strickberger, D. W. Benson, I. Biaggioni, D. J. Callans, M. I. Cohen, K. A. Ellenbogen, A. E. Epstein, P. Friedman, J. Goldberger, P. A. Heidenreich, et al. AHA/ACCF Scientific Statement on the Evaluation of Syncope: From the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation: In Collaboration With the Heart Rhythm Society: Endorsed by the American Autonomic Society Circulation, January 17, 2006; 113(2): 316 - 327. [Full Text] [PDF]
|
|
|
|
|
|
T. E. Paterick, T. J. Paterick, G. F. Fletcher, and B. J. Maron Medical and Legal Issues in the Cardiovascular Evaluation of Competitive Athletes JAMA, December 21, 2005; 294(23): 3011 - 3018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Dalal, K. Nasir, C. Bomma, K. Prakasa, H. Tandri, J. Piccini, A. Roguin, C. Tichnell, C. James, S. D. Russell, et al. Arrhythmogenic Right Ventricular Dysplasia: A United States Experience Circulation, December 20, 2005; 112(25): 3823 - 3832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B J Maron Distinguishing hypertrophic cardiomyopathy from athlete's heart: a clinical problem of increasing magnitude and significance Heart, November 1, 2005; 91(11): 1380 - 1382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K Lemola, C Brunckhorst, U Helfenstein, E Oechslin, R Jenni, and F Duru Predictors of adverse outcome in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: long term experience of a tertiary care centre Heart, September 1, 2005; 91(9): 1167 - 1172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sen-Chowdhry, P. Syrris, and W. J. McKenna Desmoplakin disease in arrhythmogenic right ventricular cardiomyopathy: early genotype-phenotype studies Eur. Heart J., August 2, 2005; 26(16): 1582 - 1584. [Full Text] [PDF]
|
|
|
|
|
|
A. Verma, F. Kilicaslan, R. A. Schweikert, G. Tomassoni, A. Rossillo, N. F. Marrouche, V. Ozduran, O. M. Wazni, S. C. Elayi, L. C. Saenz, et al. Short- and Long-Term Success of Substrate-Based Mapping and Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Dysplasia Circulation, June 21, 2005; 111(24): 3209 - 3216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Maron, P. S. Douglas, T. P. Graham, R. A. Nishimura, and P. D. Thompson Task Force 1: Preparticipation screening and diagnosis of cardiovascular disease in athletes J. Am. Coll. Cardiol., April 19, 2005; 45(8): 1322 - 1326. [Full Text] [PDF]
|
|
|
|
|
|
B. J. Maron, M. J. Ackerman, R. A. Nishimura, R. E. Pyeritz, J. A. Towbin, and J. E. Udelson Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome J. Am. Coll. Cardiol., April 19, 2005; 45(8): 1340 - 1345. [Full Text] [PDF]
|
|
|
|
|
|
K. A. Hodgkinson, P. S. Parfrey, A. S. Bassett, C. Kupprion, J. Drenckhahn, M. W. Norman, L. Thierfelder, S. N. Stuckless, E. L. Dicks, W. J. McKenna, et al. The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5) J. Am. Coll. Cardiol., February 1, 2005; 45(3): 400 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Wichter and G. Breithardt Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: A role for genotyping in decision-making? J. Am. Coll. Cardiol., February 1, 2005; 45(3): 409 - 411. [Full Text] [PDF]
|
|
|
|
|
|
W. Mullens, L. Pison, P. Vandervoort, J. Eerdekens, and P. De Vusser Multiple exercise induced syncopal episodes in a young woman due to arrhythmogenic right ventricular dysplasia Europace, January 1, 2005; 7(2): 154 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Miljoen, S. State, C. de Chillou, I. Magnin-Poull, P. Dotto, M. Andronache, A. Abdelaal, and E. Aliot Electroanatomic mapping characteristics of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia Europace, January 1, 2005; 7(6): 516 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-S. Hulot, X. Jouven, J.-P. Empana, R. Frank, and G. Fontaine Natural History and Risk Stratification of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Circulation, October 5, 2004; 110(14): 1879 - 1884. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. I. Khalil, A. Kamal, and S. Ahmad Arrhythmogenic right ventricular dysplasia presenting as acute coronary syndrome: a case report Eur J Echocardiogr, October 1, 2004; 5(5): 394 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Maron, B. R. Chaitman, M. J. Ackerman, A. Bayes de Luna, D. Corrado, J. E. Crosson, B. J. Deal, D. J. Driscoll, N.A. M. Estes III, C. G. S. Araujo, et al. Recommendations for Physical Activity and Recreational Sports Participation for Young Patients With Genetic Cardiovascular Diseases Circulation, June 8, 2004; 109(22): 2807 - 2816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Zipes The year in electrophysiology J. Am. Coll. Cardiol., April 7, 2004; 43(7): 1306 - 1314. [Full Text] [PDF]
|
|
|
|
 |
|
 Which High-Risk Patients with Arrhythmogenic RV Dysplasia Should Get ICDs? Journal Watch Cardiology, March 12, 2004; 2004(312): 3 - 3. [Full Text]
|
|
|
|
|
|
C. Basso, T. Wichter, G. A Danieli, D. Corrado, E. Czarnowska, G. Fontaine, W. J McKenna, A. Nava, N. Protonotarios, L. Antoniades, et al. Arrhythmogenic right ventricular cardiomyopathy: clinical registry and database, evaluation of therapies, pathology registry, DNA banking Eur. Heart J., March 2, 2004; 25(6): 531 - 534. [Full Text] [PDF]
|
|
|
|
|
|
R. SoRelle Cardiovascular News Circulation, December 23, 2003; 108 (25): e9081 - e9082. [Full Text]
|
|